4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-18-000028
EVP and CFO sold 2,813 shares at $3.47 ($9,773)
- EVP and CFO acquired 9,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BROWN MORGAN R EVP and CFO | 2017-12-29 | Option exercise | +9,375 | 26,375 | D | ||
| BROWN MORGAN R EVP and CFO | 2017-12-29 | Sale | −2,813 | $3.47 | $9,773 | 23,562 | D |
| Derivatives | |||||||
| BROWN MORGAN R EVP and CFO | 2017-12-29 | Option exercise · Restricted Stock Unit | −9,375 | 28,125 | D | ||
| Open-market sales · 2,813 sh · avg $3.47 · $9,773 | |||||||
Loading xslF345X03/doc4_5172.xml…